ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

Varmus calls NIH Structure “Cumbersome,” Suggests Streamlining Based On science

August 6, 1999

Funding Opportunities.

June 28, 2002

In Brief: Univ. of New Mexico Looked Over As Possible Comprehensive Center; Missouri Asks Delay

November 26, 1976

More Control Project Plans, Future RPs Listed

November 15, 1974

Q&A With The Cancer Letter: MD Anderson Provost Had No Say

May 25, 2012

Post-Hoc Analysis of ThermoDox Suggests OS Improvement

January 31, 2014